<DOC>
	<DOCNO>NCT01166360</DOCNO>
	<brief_summary>Growth determination factor 15 ( GDF-15 ) high sensitive troponin-t ( hsTnT ) emerge humoral marker risk stratification clinically stable heart failure patient patient stable coronary artery disease . No data available prognostic value peptides relation mortality morbidity patient undergoing cardiac surgery . Primary objective present study test hypothesis , GDF-15 superior standard preoperative risk score , additive Euroscore prediction 30 day mortality postoperative morbidity patient schedule cardiac surgery . Secondary objective test predictive value hsTNT , either alone , combination GDF-15 GDF-15 add additional information NTproBNP level preoperative cerebral oxygen saturation ( ScO2 ) level .</brief_summary>
	<brief_title>The Usefulness Growth Differentiation Factor 15 ( GDF-15 ) Risk Stratification Cardiac Surgery</brief_title>
	<detailed_description>The study base 2 patient cohort , group patient study observation period ( 2009 ) validation cohort patient studied 2008 . The 2009 cohort ( 800 patient ) analyze determine predictive value GDF-15 predict mortality morbidity . The 2008 cohort ( 1200 patient ) use validate finding . Besides conventional morbidity marker , new sensitive marker organ dysfunction ( FABP , NGAL , sFLT-1 , PIGF ) also test 2009 group .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients schedule cardiac surgery Withdrawal inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Risk prediction</keyword>
	<keyword>Euroscore</keyword>
	<keyword>GDF-15</keyword>
	<keyword>hsTnT</keyword>
	<keyword>cardiac surgery</keyword>
</DOC>